NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DAB.bio

DAB.bio

Private
DelftEnergy & Sustainabilityhttps://dab.bio/

Last Round

Seed

Oct 28, 2025

Total Funding Raised

$2.58M

Company Overview

DAB.bio is an industrial biotechnology company that develops and licenses advanced fermentation technology to enable cost-competitive, large-scale production of bio-based chemicals, fuels, and proteins.

Sector

Energy & Sustainability

Verticals

Biotechnology, Biotech Equipment, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Hardware Sales

AI Layer

Non-AI

Keywords

continuous fermentationbiomanufacturingISPRbio-processingin-situ product removalprocess intensificationbioreactor technologyindustrial biotechnologyextractive fermentationbio-based productionbiotech equipmentprocess engineeringtechnology licensingclean manufacturingsynthetic biology infrastructure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DAB.bio Comparables

Compare DAB.bio with similar companies based on industry and business-model similarity.

DAB.bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pow.Bio
79%
Cauldron
77%
Planetary
77%

DAB.bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 28, 2025
GrantDec 1, 2021
SeedJul 1, 2021
Series AApr 1, 2019

Key People

Founding team and executive leadership

Eric van der Meer

Chief Executive Officer

Executive Team

DAB.bio Investors

Notable investors and investment history

DAB.bio investors
InvestorRounds
Navus VenturesSeed
Mibiton FoundationGrant
Capricorn PartnersSeed
Invest-NLSeed
FORWARD.oneSeed, Series A
Delft EnterprisesSeries A
InnovationQuarterSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2021

    $340K grant received from Mibiton Foundation.

DAB.bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DAB.bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DAB.bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersDelft
Employee Range34
Year Founded2012
Last FundingOct 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.